Patrick Plewman
Known title: SVP for Diagnostic ServicesCIK: 0001497368
Associated companies
Transaction History
| DGX | ▼ Sell | Other | 46 | $10K | 7/22/2026 | View on chart |
| DGX | ▼ Sell | Other | 49 | $10K | 4/20/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 2,855 | $589K | 3/5/2026 | View on chart |
| DGX | ▲ Buy | Grant | 5,682 | $1.2M | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,827 | $579K | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 410 | $85K | 3/3/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 230 | $47K | 3/2/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 958 | $196K | 2/19/2026 | View on chart |
| DGX | ▲ Buy | Grant | 1,952 | $0 | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 293 | $61K | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 244 | $51K | 2/18/2026 | View on chart |
| DGX | ▲ Buy | Option Exercise | 5,662 | $690K | 2/10/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 5,662 | $1.2M | 2/10/2026 | View on chart |
| DGX | ▲ Buy | Grant | 48 | $9K | 1/28/2026 | View on chart |
| DGX | ▲ Buy | Grant | 46 | $9K | 10/21/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 1,975 | $365K | 8/21/2025 | View on chart |
| DGX | ▲ Buy | Option Exercise | 4,532 | $508K | 8/19/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 4,532 | $829K | 8/19/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 1,975 | $356K | 8/15/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 1,975 | $346K | 8/6/2025 | View on chart |
| DGX | ▲ Buy | Option Exercise | 3,560 | $308K | 8/6/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 3,560 | $623K | 8/6/2025 | View on chart |
| DGX | ▼ Sell | Other | 80 | $13K | 7/21/2025 | View on chart |
| DGX | ▼ Sell | Other | 81 | $13K | 4/21/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 162 | $27K | 3/26/2025 | View on chart |
| DGX | ▲ Buy | Grant | 5,674 | $986K | 3/4/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,280 | $396K | 3/4/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 106 | $18K | 3/3/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 229 | $39K | 2/26/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 320 | $54K | 2/19/2025 | View on chart |
| DGX | ▲ Buy | Grant | 2,042 | $0 | 2/12/2025 | View on chart |
| DGX | ▼ Sell | Other | 57 | $9K | 1/29/2025 | View on chart |
| DGX | ▼ Sell | Other | 60 | $9K | 10/21/2024 | View on chart |
| DGX | ▼ Sell | Other | 60 | $9K | 7/22/2024 | View on chart |
| DGX | ▲ Buy | Grant | 69 | $9K | 4/22/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 114 | $15K | 3/26/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 228 | $29K | 2/28/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 105 | $13K | 2/28/2024 | View on chart |
| DGX | ▲ Buy | Grant | 2,388 | $299K | 2/23/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 869 | $109K | 2/23/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 139 | $17K | 2/21/2024 | View on chart |
| DGX | ▲ Buy | Grant | 2,446 | $0 | 2/14/2024 | View on chart |
| DGX | ▲ Buy | Grant | 50 | $6K | 1/31/2024 | View on chart |
| DGX | ▲ Buy | Grant | 52 | $6K | 10/23/2023 | View on chart |
| DGX | ▲ Buy | Grant | 44 | $6K | 7/25/2023 | View on chart |
| DGX | ▼ Sell | Other | 44 | $6K | 4/24/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 99 | $13K | 3/24/2023 | View on chart |
| DGX | ▲ Buy | Grant | 2,579 | $381K | 3/6/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 799 | $118K | 3/6/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 90 | $13K | 3/1/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 245 | $36K | 2/23/2023 | View on chart |
| DGX | ▲ Buy | Grant | 1,919 | $0 | 2/23/2023 | View on chart |
| DGX | ▼ Sell | Other | 27 | $4K | 2/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus
Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus. Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.